AI in Neurology Market Growth Accelerated by Advances in Medical Diagnostics

Global AI in Neurology Market, By Indication (Neuro-technology, Neurosurgery), Application (Screening & Diagnosis, Treatment, Research & Development, Training, Surgical Planning and Rehabilitation, Others), Type (Oncology, Neurodegeneration, Neurovascular, Traumatic Brain Injury, Spinal Cord Injury), Technology (Machine Learning and Deep Learning, Natural Language Processing [NLP], Others), Components (Hardware, Software-as-a-Service[SaaS]), End-User (Hospitals, Diagnosis Centers, Others) - Industry Trends and Forecast to 2031.

Data Bridge Market Research analyses that the Global AI in Neurology Market which was USD 48 Billion in 2023 is expected to reach USD 716.52 Million by 2031 and is expected to undergo a CAGR of 40.20% during the forecast period of 2023 to 2031

Explore Further Details about This Research AI in Neurology Market Share Report https://www.databridgemarketresearch.com/reports/global-ai-in-neurology-market

**Segments**

- Based on technology, the AI in neurology market is segmented into machine learning, natural language processing, and others. Machine learning technology is expected to dominate the market due to its ability to process vast amounts of data and identify patterns that can assist in neurology research and diagnosis. Natural language processing is also gaining traction as it allows for the analysis of unstructured data such as patient notes and medical literature, ultimately aiding in decision-making processes within neurology.

- On the basis of application, the market is segmented into neuroimaging and diagnostics, drug discovery, electronic health records, clinical trials, and others. Neuroimaging and diagnostics hold a significant share in the market as AI technologies can enhance the process of interpreting complex imaging results and aid in the early detection of neurological disorders. The drug discovery segment is also expected to grow as AI can help in identifying potential drug candidates for neurological diseases efficiently.

- By end-users, the AI in neurology market is classified into hospitals and healthcare providers, pharmaceutical companies, research institutes, and others. Hospitals and healthcare providers are the primary end-users of AI in neurology as they heavily rely on advanced technologies to provide accurate diagnoses and treatment plans. Pharmaceutical companies are increasingly utilizing AI to expedite drug discovery processes related to neurological disorders, leading to a surge in market growth.

**Market Players**

- Some key players in the global AI in neurology market include IBM Corporation, GE Healthcare, Siemens Healthineers, Medtronic, Google LLC, NVIDIA Corporation, Microsoft Corporation, and Intel Corporation. These market players are investing heavily in research and development activities to enhance their AI technologies for applications in neurology. Collaborations, partnerships, and acquisitions are common strategies adopted by these players to expand their market presence and gain a competitive edge in the industry.

- Moreover, emerging startups such as Aidoc Medical, Subtle Medical Inc., MaxQ AI, and Cleerly are also making significant contributions to the AI in neurology market by introducing innovative solutions forThe global AI in neurology market is experiencing significant growth and evolution driven by advancements in technology, increasing applications in neurology, and a diverse range of end-users. Machine learning and natural language processing are the primary technologies segmenting the market, with machine learning expected to dominate due to its data processing capabilities and pattern recognition in neurology research and diagnosis. Natural language processing is also gaining traction for analyzing unstructured data in patient notes and medical literature, aiding decision-making processes in neurology.

In terms of applications, the market is segmented into neuroimaging and diagnostics, drug discovery, electronic health records, clinical trials, and others. Neuroimaging and diagnostics hold a significant share as AI technologies enhance interpreting complex imaging results and aid in early neurological disorder detection. The drug discovery segment is expected to grow due to AI efficiently identifying potential drug candidates for neurological diseases.

The end-users segment categorizes the market into hospitals and healthcare providers, pharmaceutical companies, research institutes, and others. Hospitals and healthcare providers are primary users of AI in neurology for accurate diagnoses and treatment plans. Pharmaceutical companies are increasingly leveraging AI in drug discovery for neurological disorders, driving market growth. Key players such as IBM Corporation, GE Healthcare, and Siemens Healthineers are investing in R&D to enhance their AI technologies. Collaborations, partnerships, and acquisitions are common strategies to expand market presence and gain a competitive edge.

Emerging startups like Aidoc Medical, Subtle Medical Inc., MaxQ AI, and Cleerly are contributing innovative solutions to the AI in neurology market. Their offerings provide new insights and advancements in the field, complementing the efforts of established market players. With ongoing technological advancements and increased adoption of AI in neurology, the market is poised for further expansion and innovation globally. Industry players will need to continue innovating and collaborating to meet the growing demand for AI-driven solutions in neurology.**Market Players**

ActivSurgical Inc. (U.S.)
Brainomix Limited (U.K.)
Caresyntax Corp (U.S.)
Neosama Inc. (Israel)
ExplORer Surgical Corp. (U.S.)
Surgalign Spine Technology Inc. (U.S.)
LeanTaaS Inc. (U.S.)
Medtronic Plc (Ireland)
Scalpel Limited (U.K.)
Theator Inc. (U.S.)

The global AI in neurology market is experiencing significant growth and evolution driven by advancements in technology, increasing applications in neurology, and a diverse range of end-users. Machine learning and natural language processing are the primary technologies segmenting the market, with machine learning expected to dominate due to its data processing capabilities and pattern recognition in neurology research and diagnosis. Natural language processing is also gaining traction for analyzing unstructured data in patient notes and medical literature, aiding decision-making processes in neurology. In terms of applications, the market is segmented into neuroimaging and diagnostics, drug discovery, electronic health records, clinical trials, and others. Neuroimaging and diagnostics hold a significant share as AI technologies enhance interpreting complex imaging results and aid in early neurological disorder detection. The drug discovery segment is expected to grow due to AI efficiently identifying potential drug candidates for neurological diseases.

The end-users segment categorizes the market into hospitals and healthcare providers, pharmaceutical companies, research institutes, and others. Hospitals and healthcare providers are primary users of AI in neurology for

Table Of Content

1 Introduction

1.1 Objectives Of The Study

1.2 AI in Neurology Market Definition

1.3 Overview

1.4 Limitations

1.5 Markets Covered

2 AI in Neurology Market Segmentation

2.1 AI in Neurology Market Covered

2.2 Geographical Scope

2.3 Years Considered For The Study

2.4 Currency And Pricing

2.5 Dbmr Tripod Data Validation Model

2.6 Multivariate Modeling

2.7 Primary Interviews With Key Opinion Leaders

2.8 Dbmr AI in Neurology Market Position Grid

2.9 Dbmr Vendor Share Analysis

2.1 Secondary Sources

2.11 Assumptions

3 Executive Summary.............

 Browse Related Reports:

https://markettrndus.blogspot.com/2024/11/flexible-packaging-ink-market.html

https://markettrndus.blogspot.com/2024/11/irrigation-controller-market-driving.html

https://markettrndus.blogspot.com/2024/11/isostearic-acid-market-supporting.html

https://markettrndus.blogspot.com/2024/11/medical-grade-silicone-market-expanding.html

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email: corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.